According to Zacks, “Orthofix International N.V. is a leading provider of high-value, minimally invasive medical devices for the orthopaedic and trauma markets. Orthofix is well positioned to expand its focus and capitalise on the growing medical acceptance of high technology in orthopaedic treatment and spine repair. The company sells its diverse product line in different countries through its subsidiaries and distribution agreements with leading orthopaedic companies, including Sulzer Medica Group, Sofamor Danek Group, Kendall Healthcare Products and B. Braun. (PRESS RELEASE) “
Separately, TheStreet lowered Orthofix International NV from a buy rating to a hold rating in a report on Wednesday, August 3rd.
Orthofix International NV (NASDAQ:OFIX) traded down 0.44% during mid-day trading on Tuesday, reaching $40.43. The company had a trading volume of 13,621 shares. The company’s 50-day moving average is $43.62 and its 200-day moving average is $43.81. The stock’s market capitalization is $732.75 million. Orthofix International NV has a one year low of $32.25 and a one year high of $48.25.
Orthofix International NV (NASDAQ:OFIX) last announced its quarterly earnings data on Monday, August 1st. The medical device company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.08. Orthofix International NV had a positive return on equity of 8.50% and a negative net margin of 0.37%. The business earned $104.10 million during the quarter, compared to analyst estimates of $102.40 million. During the same period in the prior year, the company earned $0.36 earnings per share. Orthofix International NV’s revenue was up 3.1% compared to the same quarter last year. Equities research analysts anticipate that Orthofix International NV will post $1.41 earnings per share for the current year.
In other Orthofix International NV news, insider Michael Finegan sold 25,000 shares of the stock in a transaction on Thursday, September 1st. The stock was sold at an average price of $45.16, for a total transaction of $1,129,000.00. Following the sale, the insider now owns 51,670 shares in the company, valued at $2,333,417.20. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 5.10% of the company’s stock.
Large investors have recently modified their holdings of the company. Norges Bank acquired a new stake in shares of Orthofix International NV during the fourth quarter worth about $9,643,000. TIAA CREF Investment Management LLC increased its stake in shares of Orthofix International NV by 4.7% in the first quarter. TIAA CREF Investment Management LLC now owns 95,843 shares of the medical device company’s stock worth $3,979,000 after buying an additional 4,269 shares during the period. Algert Global LLC acquired a new stake in shares of Orthofix International NV during the first quarter worth about $373,000. Goldman Sachs Group Inc. increased its stake in shares of Orthofix International NV by 59.7% in the first quarter. Goldman Sachs Group Inc. now owns 65,550 shares of the medical device company’s stock worth $2,721,000 after buying an additional 24,513 shares during the period. Finally, Bogle Investment Management L P DE increased its stake in shares of Orthofix International NV by 37.6% in the first quarter. Bogle Investment Management L P DE now owns 81,833 shares of the medical device company’s stock worth $3,397,000 after buying an additional 22,365 shares during the period. Institutional investors own 91.26% of the company’s stock.
About Orthofix International NV
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthofix International NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International NV and related companies with MarketBeat.com's FREE daily email newsletter.